Cite
APA Citation
Brandes, J. L., Diener, H., Dolezil, D., Freeman, M. C., McAllister, P. J., Winner, P., Klatt, J., Cheng, S., Zhang, F., Wen, S., Ritter, S., Lenz, R. A., & Mikol, D. D. (2020). the spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response. Cephalalgia, 40, 28–38. http://access.bl.uk/ark:/81055/vdc_100095729776.0x00002a